CTRI/2015/07/005998
已完成
未知
Prospective Screening log for patients with recurrent or second primary Head and Neck Cancers referred for re-Radiotherapy.
概览
- 阶段
- 未知
- 干预措施
- 未指定
- 疾病 / 适应症
- Health Condition 1: null- All patients with head and neck cancers who are referred for re-radiation
- 发起方
- Tata Memorial Hospital
- 入组人数
- 250
- 状态
- 已完成
- 最后更新
- 4年前
概览
简要总结
暂无简介。
研究者
入排标准
入选标准
- •1\.Patients must have recurrence at least 6 months after prior radiotherapy.
- •2\.Patients should have histopathological proof for both the primary tumor and at recurrence / second cancer in the upper aero\-digestive tract
- •3\.Patients should have been treated with radical intent for primary tumor with appropriate radical doses of radiation
- •4\.Patients who are diagnosed with recurrent or second cancer for which the radiation portals will overlap the fields of previously irradiated region
排除标准
- 未提供
结局指标
主要结局
未指定
相似试验
招募中
不适用
Patient-based screening register of a consecutive patient cohort for cystic pancreatic masses (Magdeburg cyst passport concept)K86.2K86.3K86.8K86.9Cyst of pancreasPseudocyst of pancreasOther specified diseases of pancreasDisease of pancreas, unspecifiedDRKS00033939niversitätsklinik für Allgemein-, Viszeral-, Gefäß- und Transplantationschirurgie1,000
招募中
不适用
A prospective observational registry of patients with acute ischemic stoke or transient ischemic attack in the Department of Neurology, Tokyo Women's Medical University HospitalJPRN-UMIN000031913Tokyo Women's Medical University1,000
招募中
不适用
Prospective registry study to evaluate recurrences and complications after surgical treatment of male stress incontinence with DynaMesh®-PRM mesh implantsN39.3Stress incontinenceDRKS00032228FEG Textiltechnik Forschungs- und Entwicklungsgesellschaft mbH80
进行中（未招募）
1 期
Follow-up Study for Patients who Completed Study ALX0681-C301 (Post-HERCULES)Acquired thrombotic thrombocytopenic purpura (TTP)MedDRA version: 20.0Level: PTClassification code 10043648Term: Thrombotic thrombocytopenic purpuraSystem Organ Class: 10005329 - Blood and lymphatic system disordersTherapeutic area: Diseases [C] - Blood and lymphatic diseases [C15]EUCTR2016-001503-23-ATAblynx NV104
尚未招募
3 期
Prospective Follow-up Study for Patients who Completed Study ALX0681-C301 (HERCULES) to Evaluate Long-term Safety and Efficacy of Caplacizumab (Post-HERCULES)Thrombotic Thrombocytopenic Purpura10038158NL-OMON43030Ablynx NV8